Compounds > isoxazoles
Page last updated: 2024-08-21

isoxazoles and Cancer-Associated Pain

isoxazoles has been researched along with Cancer-Associated Pain in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Alexander, M; Dines-Muntaner, S; Fullerton, S; Thakerar, A; Trifunovich, T1
Berman, R; Collins, J; Kellett, E; Morgan, H1
Armstrong, P; McCorry, NK; Wilkinson, P1
Chen, J; Cong, X; Zhan, X; Zheng, W; Zhou, Z1
Lin, W; Liu, BL; Pan, HL; Zhang, YQ1

Other Studies

5 other study(ies) available for isoxazoles and Cancer-Associated Pain

ArticleYear
Parecoxib as an adjunct therapy for the treatment of refractory non-surgical cancer pain.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2020, Volume: 26, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Australia; Cancer Pain; Cohort Studies; Drug Therapy, Combination; Female; Humans; Isoxazoles; Male; Middle Aged; Neoplasms; Pain Measurement; Retrospective Studies; Young Adult

2020
Parecoxib for opioid-induced hyperalgesia.
    BMJ supportive & palliative care, 2021, Volume: 11, Issue:2

    Topics: Adult; Analgesics, Opioid; Cancer Pain; Humans; Hyperalgesia; Isoxazoles; Male; Treatment Outcome

2021
Use of parecoxib by continuous subcutaneous infusion for cancer pain in a hospice population.
    BMJ supportive & palliative care, 2018, Volume: 8, Issue:1

    Topics: Adult; Aged; Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Cancer Pain; Female; Hospice Care; Hospices; Humans; Infusions, Subcutaneous; Isoxazoles; Male; Middle Aged; Pain Management; Pain Measurement; Retrospective Studies; Treatment Outcome

2018
Effects of Parecoxib on Pain Threshold and Inflammatory Factors IL-1β, IL-6 and TNF-
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2019, Volume: 29, Issue:6

    Topics: Animals; Bone Neoplasms; Cancer Pain; Cyclooxygenase 2 Inhibitors; Down-Regulation; Female; Hyperalgesia; Inflammation; Interleukin-1beta; Interleukin-6; Isoxazoles; Pain Threshold; Random Allocation; Rats; Rats, Sprague-Dawley; Spinal Cord; Tumor Necrosis Factor-alpha

2019
Modulation of Nav1.8 by Lysophosphatidic Acid in the Induction of Bone Cancer Pain.
    Neuroscience bulletin, 2016, Volume: 32, Issue:5

    Topics: Animals; Biophysics; Bone Neoplasms; Cancer Pain; Carcinoma; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Female; Ganglia, Spinal; Gene Expression Regulation, Neoplastic; Hyperalgesia; Isoxazoles; Lysophospholipids; Membrane Potentials; NAV1.8 Voltage-Gated Sodium Channel; Neurons; Pain Measurement; Patch-Clamp Techniques; Propionates; Rats; Rats, Sprague-Dawley; Receptors, Lysophosphatidic Acid

2016